Beta variant COVID-19 protein booster vaccine elicits durable cross-neutralization against SARS-CoV-2 variants in non-human primates

Waning protective efficacy of mRNA-based booster vaccinations has been observed against newly emerging SARS-CoV-2 variants of concern. In this work, Pavot et al. formulate a monovalent Beta vaccine and demonstrate durable cross-neutralising antibody responses in non-human primates, against a spectru...

Volledige beschrijving

Bibliografische gegevens

Hoofdauteurs:	Vincent Pavot, Catherine Berry, Michael Kishko, Natalie G. Anosova, Lu Li, Tim Tibbitts, Dean Huang, Alice Raillard, Sylviane Gautheron, Cindy Gutzeit, Marguerite Koutsoukos, Roman M. Chicz, Valerie Lecouturier
Formaat:	Artigo
Taal:	Inglês
Gepubliceerd in:	Nature Portfolio 2023-03-01
Reeks:	Nature Communications
Online toegang:	https://doi.org/10.1038/s41467-023-36908-z
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!